PTP22 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PTP22 monoclonal antibodies for investigating PTP22's role in cellular processes. PTP22 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PTP22, a member of the protein tyrosine phosphatase family, plays a critical role in regulating cellular signaling pathways that influence cell growth, differentiation, and immune responses. Research has shown that PTP22 activity significantly impacts cancer development and autoimmune conditions. Understanding PTP22 mechanisms can reveal potential therapeutic targets for various diseases. Scientists worldwide use PTP22 monoclonal antibodies to advance research in cell signaling and disease pathways. Current studies focusing on PTP22 continue to uncover new insights into cellular regulation and disease progression. PTP22 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to scientific understanding of cellular signaling and disease mechanisms.